|
|
Article: Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen.(Statistical Data Included)
- Article from:
- Vaccine Weekly
- Article date:
- October 11, 1999
CopyrightCOPYRIGHT 1999 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cancer Vaccines
Foon, K.A.; John, W.J.; Chakraborty, M.; Das, R.; Teitelbaum, A.; Garrison, J.; Kashala, O.; Chatterjee, S.K.; Bhattacharyachatterjee, M. "Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen." Journal of Clinical Oncology, September 1999;17(9):2889-2895.
(CW HENDERSON PUBLISHER www.newsfile.com) -- According to the authors' abstract of an article published in Journal of Clinical Oncology, "PURPOSE: We generated an anti-idiotype antibody, designated CeaVac, that is an internal image of the carcinoembryonic antigen (CEA). We ...